Prosecution Insights
Last updated: October 02, 2026

Examiner: AZPURU, CARLOS A

Tech Center 3700 • Art Units: 1611 1612 1615 1616 1617 3774

This examiner grants 84% of resolved cases

Analysis

Carlos A. Azpuru, working in Art Unit 1611 within Tech Center 3700, has handled a volume of 1297 resolved cases. His allowance rate of 83.8% indicates a high probability of success for applications assigned to his docket. The median days to allowance stands at 965, providing a clear benchmark for the expected duration of the prosecution process.

The data shows an interview lift of 10.7% over the 83.8% baseline, which provides a moderate boost to the chances of success. For practitioners, this suggests that while written arguments are often successful, an interview can be a valuable tool to resolve final disagreements. Managing 1297 resolved cases demonstrates significant experience, and the 965-day timeline suggests a consistent pace of resolution. Applicants can feel confident in the high baseline of success while using interviews strategically to further improve their odds beyond the initial 83.8% rate.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

83.8%
Allow Rate
+13.8% vs TC avg
1,322
Total Applications
+10.7%
Interview Lift
965
Avg Prosecution Days
Based on 1297 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
19.9%
§102 Novelty
24.5%
§103 Obviousness
30.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19562371 OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR Non-Final OA OCULAR THERAPEUTIX, INC.
18733177 DEODORANT AND ANTIPERSPIRANT COMPOSITIONS Non-Final OA The Procter & Gamble Company
18443360 COSMETIC INK COMPOSITION COMPRISING A SURFACE TENSION MODIFIER Non-Final OA The Procter & Gamble Company
18599800 USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION Non-Final OA Allergan, Inc.
18402685 SYSTEMS AND METHODS TO ACCELERATE GEL-SOL TRANSITION FOR THERMORESPONSIVE HYDROGELS Non-Final OA University of Southern California
18790605 SYSTEM AND METHOD OF ATTACHING SOFT TISSUE TO AN IMPLANT Non-Final OA PURDUE RESEARCH FOUNDATION
18695487 COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS Non-Final OA The Trustees Of The University of Pennsylvania
18682824 METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION Non-Final OA CHEMO RESEARCH, S.L.
18409546 LIPID PRODRUGS OF NEUROSTEROIDS Non-Final OA Monash University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month